Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lynparza Granted Orphan Drug Designation in Japan for Pancreatic Cancer

americanpharmaceuticalreviewMarch 23, 2020

Tag: Lynparza , Pancreatic cancer , AstraZeneca , Cancer

PharmaSources Customer Service